STOCK TITAN

Aurinia Pharmaceuticals Inc (AUPH) Net Income by Year

AUPH

Aurinia Pharmaceuticals Inc reported $287.2M in net income in fiscal year 2025. This represents an increase of 4851.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $314.1M in net income. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Aurinia Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Net Income $287.2M
YoY +4851.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AUPH Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income$314.1M$287.2M+4851.7%$5.8M+107.4%-$78.0M+27.9%-$108.2M+40.2%-$181.0M-76.3%-$102.7M-16.2%-$88.4M-66.5%-$53.1M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

AUPH Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-KQ1'2410-KQ4'2310-KQ3'2310-K
Net Income$37.4M+73.9%$34.4M+47.2%$210.8M+14651.2%$31.6M+119.9%$21.5M+2879.6%$23.3M+317.2%$1.4M+105.3%$14.3M+206.7%$722K+106.3%-$10.7M+59.0%-$26.9M-3.2%-$13.4M-49.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Aurinia Pharmaceuticals Inc financials

Frequently Asked Questions

What was Aurinia Pharmaceuticals Inc's net income in fiscal year 2025?

Aurinia Pharmaceuticals Inc reported $287.2M in net income in fiscal year 2025.

How fast is Aurinia Pharmaceuticals Inc's net income growing?

Aurinia Pharmaceuticals Inc (AUPH) net income rose by 4851.7% year over year, from $5.8M to $287.2M in fiscal year 2025.

What is Aurinia Pharmaceuticals Inc's net income over the last twelve months?

Aurinia Pharmaceuticals Inc (AUPH) reported $314.1M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 8 fiscal years this page covers, Aurinia Pharmaceuticals Inc (AUPH) net income went from -$53.1M in fiscal year 2018 to $287.2M in fiscal year 2025.

Aurinia Pharmaceuticals Inc (AUPH) reported $37.4M in net income in Q2 2026. This represents an increase of 73.9% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Aurinia Pharmaceuticals Inc (AUPH) reported on that line in every period on record.